RxDoctor Payments Data

Whitney Prater

Psychiatric/Mental Health · Longview, TXNPI 1659962645

Payments from drug & device makers

$2,523in general payments, 2019–2025

Across 148 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$462
  • Johnson & Johnson$334
  • AbbVie$313
  • Viiv Healthcare Company$259
  • Teva Pharmaceuticals USA, Inc.$197
  • Sunovion Pharmaceuticals Inc.$156
  • plus $801 from 16 others

What the payments were for

  • Food & beverage$2,44297%
  • Education$813%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,523 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate25$219,961
RexultiBrexpiprazole42$60,494
VraylarCariprazine Hcl29$43,921
Risperdal ConstaRisperidone Microspheres12$27,057
TrintellixVortioxetine Hydrobromide43$23,657
Olanzapine33$4,155
Lurasidone Hcl25$3,254
Quetiapine Fumarate194$2,902
Atomoxetine Hcl34$2,646
Duloxetine Hcl56$2,130
Clozapine13$2,101
Paliperidone ErPaliperidone14$1,987
Trazodone Hcl236$1,909
Hydroxyzine Hcl70$1,510
Ziprasidone Hcl16$1,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$462$219,96125 claims
Otsuka America Pharmaceutical, Inc.Rexulti$82$60,49442 claims
AbbVieVraylar$313$43,92129 claims
Johnson & JohnsonRisperdal Consta$334$27,05712 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$127$23,65743 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Longview

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →